What it is
Blood pressure of 140/90 or higher on two readings at least 4 hours apart meets the definition of high blood pressure in pregnancy. Chronic hypertension is present before pregnancy or before 20 weeks; gestational hypertension appears after 20 weeks without protein in the urine or organ involvement; preeclampsia adds those features. Even without preeclampsia, high blood pressure raises the risk of growth restriction, placental abruption, preterm birth, and progression to preeclampsia — so it is monitored closely and often treated with medication when readings stay high.
Evidence review links
Each link opens the full review on the publisher's site in a new tab.
- ACOG Practice Bulletin 203: Chronic Hypertension in PregnancyACOG
- ACOG Practice Bulletin 222: Gestational Hypertension and PreeclampsiaACOG
- ACOG Committee Opinion 743: Low-Dose Aspirin Use for the Prevention of PreeclampsiaACOG
- Treatment for Mild Chronic Hypertension during Pregnancy (CHAP trial)New England Journal of Medicine
- Preeclampsia and Long-Term Cardiovascular Risk (Scientific Statement)American Heart Association
Possible benefits
- Treating blood pressure in the severe range (≥160/110) prevents strokes and other serious events[ACOG↗][ACOG↗]
- Newer evidence (CHAP trial) shows treating mild chronic hypertension (≥140/90) also improves outcomes[New England Journal of Medicine↗]
- Regular monitoring catches progression to preeclampsia early[ACOG↗]
Possible risks
- Untreated or poorly controlled high blood pressure can lead to stroke, placental abruption, growth restriction, and preterm birth[ACOG↗][ACOG↗]
- Blood pressure medications have side effects; some are avoided in pregnancy (e.g., ACE inhibitors, ARBs)[ACOG↗]
- May lead to earlier induction or cesarean, especially if preeclampsia develops[ACOG↗]
- Higher long-term risk of heart disease and stroke — postpartum follow-up is important[American Heart Association↗]
Alternatives
- Lifestyle steps (movement, sleep, stress reduction, sodium awareness) alongside — not instead of — medical management when needed[ACOG↗]
- Home blood-pressure monitoring with a validated cuff and shared readings between visits[ACOG↗]
- Pregnancy-safe blood pressure medications: labetalol, nifedipine, methyldopa[ACOG↗]
- Low-dose aspirin from 12–28 weeks in people at high risk for preeclampsia[ACOG↗]
Current evidence
ACOG Practice Bulletin 203 covers chronic hypertension in pregnancy; Practice Bulletin 222 covers gestational hypertension and preeclampsia. The 2022 CHAP trial found treating mild chronic hypertension to a target below 140/90 improved outcomes without increasing small-baby rates, changing prior practice.
Where the evidence is clear · where people may choose differently
For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.
Educational only. Your care team can help you weigh what applies to your specific situation.
Related evidence topics
Questions to ask your care team
- ?Which type of high blood pressure do I have, and what number are you treating to?
- ?Should I be checking my blood pressure at home? How often, and when should I call?
- ?Am I a candidate for low-dose aspirin to lower my preeclampsia risk?
- ?Which medications are safe if I need one, and what are the side effects?
- ?How will high blood pressure change decisions about induction and monitoring?
Universal questions (works for any decision)
A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.
- ?Why are you recommending this now — is it urgent, routine, or optional?
- ?What happens if we wait an hour (or longer) before deciding?
- ?What signs would tell us this is working — or that we need to change course?
- ?What are the alternatives, including doing nothing?
- ?What would you recommend if this were your family?
- ?What would change your recommendation?
Sources & provenance
Tap a source to open the original guideline or review in a new tab.
- ACOG Practice Bulletin 203: Chronic Hypertension in Pregnancy — ACOG
- ACOG Practice Bulletin 222: Gestational Hypertension and Preeclampsia — ACOG
- ACOG Committee Opinion 743: Low-Dose Aspirin Use for the Prevention of Preeclampsia — ACOG
- Treatment for Mild Chronic Hypertension during Pregnancy (CHAP trial) — New England Journal of Medicine
- Preeclampsia and Long-Term Cardiovascular Risk (Scientific Statement) — American Heart Association
Written in plain language from general guidance published by the listed organizations. No verbatim excerpts; editors should re-verify thresholds and medication guidance against the current source versions before publish.
Last reviewed: 2026-07-03
Further reading — canonical references
Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.
Tier 1 · Clinical guidelines
Tier 2 · Systematic reviews
Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.
Version history — v1.0.0
v1.0.0 · 2026-07-03 · LlaMamma editors
Initial hypertension-in-pregnancy topic added with ACOG, CHAP trial, and AHA references.
New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.
